1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ophthalmic Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Prescription Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over-the-counter Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Anti-glaucoma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anti-infection
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Anti-inflammation
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Indication
8.1 Dry Eye
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Glaucoma
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infection/Inflammation/Allergy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Retinal Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Dosage Form
9.1 Liquid Ophthalmic Drug Forms
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Solid Ophthalmic Drug Forms
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Semisolid Ophthalmic Drug Forms
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Multicompartment Drug Delivery Systems
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Drug Stores
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Aerie Pharmaceuticals Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Akorn Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Alcon
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Bausch Health Companies Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Bayer AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 F. Hoffmann-La Roche AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Johnson & Johnson
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Merck & Co. Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novartis AG
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Regeneron Pharmaceuticals Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Santen Pharmaceutical Co. Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Sun Pharmaceutical Industries Ltd.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
List of Figures
Figure 1: Global: Ophthalmic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Ophthalmic Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Ophthalmic Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Ophthalmic Drugs Market: Breakup by Type (in %), 2024
Figure 5: Global: Ophthalmic Drugs Market: Breakup by Drug Class (in %), 2024
Figure 6: Global: Ophthalmic Drugs Market: Breakup by Indication (in %), 2024
Figure 7: Global: Ophthalmic Drugs Market: Breakup by Dosage Form (in %), 2024
Figure 8: Global: Ophthalmic Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 9: Global: Ophthalmic Drugs Market: Breakup by Region (in %), 2024
Figure 10: Global: Ophthalmic Drugs (Prescription Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Ophthalmic Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Ophthalmic Drugs (Anti-glaucoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Ophthalmic Drugs (Anti-glaucoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Ophthalmic Drugs (Anti-infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Ophthalmic Drugs (Anti-infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Ophthalmic Drugs (Anti-inflammation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Ophthalmic Drugs (Anti-inflammation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Ophthalmic Drugs (Anti-allergy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Ophthalmic Drugs (Anti-allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Ophthalmic Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Ophthalmic Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Ophthalmic Drugs (Dry Eye) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Ophthalmic Drugs (Dry Eye) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Ophthalmic Drugs (Glaucoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Ophthalmic Drugs (Glaucoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Ophthalmic Drugs (Retinal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Ophthalmic Drugs (Retinal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Ophthalmic Drugs (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Ophthalmic Drugs (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Global: Ophthalmic Drugs (Other Dosage Forms) Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Global: Ophthalmic Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Global: Ophthalmic Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Global: Ophthalmic Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Global: Ophthalmic Drugs (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Global: Ophthalmic Drugs (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Global: Ophthalmic Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Global: Ophthalmic Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Global: Ophthalmic Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Global: Ophthalmic Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: North America: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: North America: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United States: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United States: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Canada: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Canada: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Asia-Pacific: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Asia-Pacific: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: China: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: China: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Japan: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Japan: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: India: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: India: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: South Korea: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: South Korea: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Australia: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Australia: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Indonesia: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Indonesia: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Europe: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Europe: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Germany: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Germany: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: France: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: France: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: United Kingdom: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: United Kingdom: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Italy: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Italy: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Spain: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Spain: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Russia: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Russia: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Others: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Latin America: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 91: Latin America: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Brazil: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 93: Brazil: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Mexico: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 95: Mexico: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 96: Others: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 97: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 98: Middle East and Africa: Ophthalmic Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 99: Middle East and Africa: Ophthalmic Drugs Market: Breakup by Country (in %), 2024
Figure 100: Middle East and Africa: Ophthalmic Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 101: Global: Ophthalmic Drugs Industry: SWOT Analysis
Figure 102: Global: Ophthalmic Drugs Industry: Value Chain Analysis
Figure 103: Global: Ophthalmic Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Ophthalmic Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Ophthalmic Drugs Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Ophthalmic Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 4: Global: Ophthalmic Drugs Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 5: Global: Ophthalmic Drugs Market Forecast: Breakup by Dosage Form (in Million USD), 2025-2033
Table 6: Global: Ophthalmic Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 7: Global: Ophthalmic Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Ophthalmic Drugs Market: Competitive Structure
Table 9: Global: Ophthalmic Drugs Market: Key Players